Autres langues Celcuity Inc.

Actions

CELC

US15102K1007

Temps réel estimé Cboe BZX Autres places de cotation 16:25:44 29/04/2024			Varia. 5j.	Varia. 1 janv.
16,52 ^USD	+3,74 %		-7,57 %	+11,27 %

28/03	CELCUITY INC. : Craig-Hallum toujours positif	ZM
28/03	CELCUITY INC. : Needham & Co. maintient sa recommandation à l'achat	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Celcuity To Present at Upcoming Needham and Stifel Investor Conferences	04/04
Celcuity Inc. Enters into Second Amendment to its Existing Loan and Security Agreement	29/03
Celcuity Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	27/03
Celcuity Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/03
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call	20/03
Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024	06/03
Celcuity to Participate in Cowen’s 44th Annual Health Care Conference	28/02
Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer	22/02
Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer	22/02
Celcuity Appoints Eldon Mayer as Chief Commercial Officer	20/02
Celcuity Appoints Eldon Mayer as Chief Commercial Officer	20/02
Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium	06/12
Celcuity Inc. Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium	06/12
Celcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer Symposium	01/12
Celcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference	22/11
Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates	13/11
Celcuity Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
North American Morning Briefing : Stock Futures Dip as Inflation Data Looms	13/11
Celcuity Inc. Schedules Release of Third Quarter 2023 Financial Results and Webcast/Conference Call	06/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Celcuity Inc.

Actions

CELC

US15102K1007

Autres langues

Filtres